High-throughput structural biology of metabolic enzymes and its impact on human diseases.
The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the struc...
Main Authors: | Yue, W, Oppermann, U |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2011
|
Registos relacionados
-
High-throughput structural biology of metabolic enzymes and its impact on human diseases
Por: Yue, W, et al.
Publicado em: (2011) -
High-throughput structural biology of metabolic enzymes and its impact on human diseases.
Por: Yue, W, et al.
Publicado em: (2011) -
Structural genomics and high throughput structural biology /
Por: Sundstrom, Michael, et al.
Publicado em: (2006) -
Structural genomics and drug discovery: Case studies on human metabolic enzymes
Por: Oppermann, U, et al.
Publicado em: (2007) -
Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions.
Por: Oppermann, U, et al.
Publicado em: (2000)